Tender notice from Bulgaria, published on 27 Jun 2019.
Executive Summary
The „???? — ???????“ ???? has issued a Tender notice for the procurement of a Contract notice: Pharmaceutical products in the Bulgaria. This Tender notice was published on 27 Jun 2019 and is scheduled to close on 01 Aug 2019, with an estimated Tender value of Refer Document.
Interested bidders can access detailed Tender information, eligibility criteria, and complete bidding documents by referencing TOT Ref No. 34207051, while the tender notice number is 297986-2019 and Register on the platform.
Object of the contract Pharmaceutical products Description: Contract notice: Pharmaceutical products Authority Type: Body governed by public law Contact Nature: Supplies Procedure: Open procedure Document: Contract notice Regulation: European Union Award criteria: Lowest price CPV code: 33600000, 33610000, 33600000, 33610000, 33611000, 33612000, 33613000, 33614000, 33615000, 33615100, 33616000, 33621000, 33651100, 33651400, 33651200, 33621200, 33621300, 33622000, 33622100, 33622200, 33622300, 33622400, 33622600, 33622700, 33622800, 33631000, 33632100, 33632200, 33632300, 33641200, 33642200, 33661000, 33660000, 33661100, 33661200, 33661500, 33661600, 33661700, 33662100, 33670000, 33674000, 33675000, 33692100, 33692500, 33692700, 33696000, 33651520, 15893000, 33690000, 33692800, 33692600 CPV Description: Pharmaceutical products. Medicinal products for the alimentary tract and metabolism. Medicinal products for acid related disorders. Medicinal products for functional gastrointestinal disorders. Laxatives. Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents. Medicinal products used in diabetes. Insulin. Vitamins. Medicinal products for the blood and blood-forming organs. Antibacterials for systemic use. Antivirals for systemic use. Antimycotics for systemic use. Antihaemorrhagics. Antianaemic preparations. Medicinal products for the cardiovascular system. Cardiac therapy medicinal products. Antihypertensives. Diuretics. Vasoprotectives. Beta-blocking agents. Calcium channel blockers. Agents acting on the renin-angiotensin system. Medicinal products for dermatology. Anti-inflammatory and anti-rheumatic products. Muscle relaxants. Antigout preparations. Other gynaecologicals. Corticosteroids for systemic use. Medicinal products for the nervous system. Medicinal products for the nervous system and sensory organs. Anaesthetics. Analgesics. Psycholeptics. Psychoanaleptics. Other nervous system medicinal products. Ophthalmologicals. Medicinal products for the respiratory sInsectable solutions - Glucose solutions - Reagents and contrast media - Immunoglobulins - Dry goods - Various medicinal products - Dialysis solutions - Galenic Delivery of medicinal products for the needs of MHAT - Samokov EOOD The subject of the public procurement contract is divided into 49 (forty nine) reasonsbordered positions with indicated anatomical-therapeutic code (ATC) and international non-proprietary name (INN). Each participant in the procedure may submit a proposal for 1 or more lots. Each participant may bid 1, several or all nomenclature units from the respective lot. You are not allowed to submit variants in the offer. Main Site: Hospital Pharmacy of the University Hospital SamokovThe object of the public procurement contract is divided into 49 (forty nine) lots with anatomical-therapeutic code (ATC) and an international non-proprietary name (INN), located in the town of Samokov, ). Each participant in the procedure may submit a proposal for 1 or more lots. Each participant may bid 1, several or all nomenclaturesunits of the respective segregated item. Variants are not allowed to be submitted in the offer. Validity of the offer - 120 calendar days OP 1: 1.1. Ademetoin, tablet formulation. 500 mg 1.2. Ademetoin, powd dosage form. 500 mg sol 1.3. Essentiale phspholipida 1.4. Fluocortolone-pivalate / lidocaine hydrochloride 1.5. L-ornithine-L-aspartate, pharmaceutical form amp. 5 g / 10 ml 1.6. L-ornithine-L-aspartate, pharmaceutical form sach. 3 g 1.7. Macrogol, pharmaceutical form sach. 64 g 1.8. Ursodeoxycholic, dosage form caps 250 mg 1.9. Senna glicozides, pharmaceutical form sol. 75 ml 1.10. Silymarin, a pharmaceutical form caps. 90 mg 1.11. Silymarin, medicine form dr. 22.5 mg The participation documentation is published and can be downloaded from the buyer's siteof the MHAT Samokov EOOD: http://www.mbal-samokov.com/procurement.html on the day of publication of the decision and the announcement in the ROP. The quantities of the medicinal products specified in the technical specification - Annex 5 of the documentation for the participation are predictive and do not oblige the client to purchase them in their full volume.The quantities for each nomenclature in the lots are indicatedin the technical specification. Specific deliveries are determined by the needs of the medical establishment. Minimum requirements for fitness for exercise of professional activity: 1.1. For all lots: The participant must hold a manufacturing authorization issued under the LMPHM (in the cases under Article 196 (1) of LMPHM) or for wholesale trade in medicinal products(in the cases referred to in Article 195 (1) and (2) of the LMPHM) or an import permit (the cases under Article 196 (2) of LMPHM) issued under LMPHM procedures ● Documents for / how to prove the selection criterion: In EEDOP, the participant notes the number of the production license issued in his name, issued under the LMPHM or for marketingwholesale of medicinal products or a certificate for registration for wholesale of medicines or an import permit issued under the LMPHM in order to ensure that the contracting authority can consult the relevant public register. 67, para. 5 of the PPA the contracting authority may require documents proving the information declared in EEDOP 1.2. For all segregated by: The participant to hold a license under Art. 32 of the Narcotic Substances and Precursors Control Act (ACFA) when it participates in the supply of medicinal products containing narcotic substances in accordance with the Ordinance on Classification of Plants and Substances as Narcotic Drugs Documents for / how to prove the selection criterion: The EEDOP participant shall mark the license number under Art. 32 of the Narcotic Drugs and Precursors Control Act (ACFA) for medicinal products containing narcotic substances from Annexes 2 and 3 to Art. 3, item 2 and 3 of the Ordinance for classification of plants and substances as narcotic, in order to ensure the possibility of the contracting authority to consult the respective public register. 67, para. 5 of the PPA, the contracting authority may requiredocuments that prove the information stated in EEDOP. The Contracting Authority has no requirements regarding the economic and financial status of the participants. which are grounds for removal of the subject. and honored. of their absence: has been convicted of having entered into force, unless it is rehabilitated, for an offense under Articles 108a, 159a-159d, Art.172, Art.192a, Art.194-217, Art.219-252, art. 253-260, art. 301-307, art. 321, 321a and Art. 352 - 353f of the Criminal Code, has been convicted with an enforceable sentence for an offense analogous to the one under item 1 in another Member State or third party, there are tax and compulsory insurance contributions within the meaning of Article 162, paragraph 2, item 1 of the TIPC and the interest thereon, to the state or to a general one. at the headquarters of node. and the candidate or student, or similar obligations under a lawthe jurisdiction of the state in which the applicant or the participant is established proven by an act of a competent authority which has entered into force, there is an inequality in the cases under Art. 44, para. (5) of the Public Procurement Act, it has been established that: (a) he has produced a false document related to the verification of the absence of grounds for removal or the fulfillment of the selection criteria, (b) did not provide the required information relating toverifying the lack of grounds for removal. or the fulfillment of the selection criteria, has been established by a punitive decree or a court decision which has entered into force, 61, para 1, art.62, para 1 or 3, art.63, para 1 or 2, art.118, art.128, art.228, para.3, art.245 and art.301- 305 of the Labor Code or Article 13, Paragraph 1 of the Labor Migration and Labor Mobility Act, there is a conflict of interest which can not be eliminatedhas been declared insolvent or bankrupt or is in liquidation or has concluded an out-of-court agreement with its creditors within the meaning of Article 740 of the Commercial Code or has ceased its activity and if the applicant or participant is a foreign person - is in a similar situation arising from a similar procedure under the law of the State where theunless otherwise provided by the Applicant / Participant in the circumstances of the case.55, paragraph 4 of the Public Health Information Act. General requirements for the proposed medicinal products The proposed medicinal products must comply with the requirements of LMPHM must be validly authorized in the the country issued under the LMPHM or Regulation (EC) No 726/2004 of the European Parliament and of the Council (Articles 23, In the cases under art. 55, para 6 of LMPHM, the participant declares that the quantities for the medicinal product are available. The contract price, concluded on the basis of the present procedure is fixed, is not subject to change for the term of validity of the contract, except in the cases of 116, para. 2, in conjunction with Art. 116, para. 1, item 3 of the Public Procurement Act. Term for delivery of medication: It must be done within 3 daysupon receipt of a written request from Nest and, if necessary, up to 3 hours. The shelf life of delivered goods remaining after the date of receipt by the Contracting Authority should be no less than 75% of the total expiry date indicated by production. Dop. requirements: Subjects bidding on the market should comply with LMPHM requirements. Targeted medicinal products should be authorized(Article 26, in conjunction with Article 23 (1) of the LMPHM), issued in accordance with the LMPHM or Regulation (EC) No 726/2004 of the European Parliament and of the Council. Offer. prices of medicines included in Appendix 2 to the PLL should not be higher than the National Drug Products and Reimbursement Council (HC) Ref. you need to have a medical prescriptionof opening offers. Offer. the prices of all other medicinal products other than those mentioned in item 2.3 must not exceed the limit value in accordance with the Ordinance on the Limit Values of the Licensed Medicinal Products. For the duration of the contract, a license for wholesale of narcotic substances and drug products, drug-to-study drugs, prescription drug, volect on ZKNVP. Internet address (URL): http://www.mbal-samokov.com/
The bid deadline for Contract notice: Pharmaceutical products was 01 Aug 2019. Bidding is closed.
This tender has been issued by „???? — ???????“ ???? in Bulgaria.
The tender value is not disclosed; please refer to the tender document. EMD / bid security details are provided in the tender document.
This tender is Self Financed
The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products, 33610000 - Medicinal products for the alimentary tract and metabolism, 33611000 - Medicinal products for acid related disorders, 33612000 - Medicinal products for functional gastrointestinal disorders, 33613000 - Laxatives, 33614000 - Antidiarrhoeals, intestinal anti-inflammatory/anti-infective agents, 33615000 - Medicinal products used in diabetes, 33615100 - Insulin, 33616000 - Vitamins, 33621000 - Medicinal products for the blood and blood-forming organs, 33651100 - Antibacterials for systemic use, 33651400 - Antivirals for systemic use, 33651200 - Antimycotics for systemic use, 33621200 - Antihaemorrhagics, 33621300 - Antianaemic preparations, 33622000 - Medicinal products for the cardiovascular system, 33622100 - Cardiac therapy medicinal products, 33622200 - Antihypertensives, 33622300 - Diuretics, 33622400 - Vasoprotectives, 33622600 - Beta-blocking agents, 33622700 - Calcium channel blockers, 33622800 - Agents acting on the renin-angiotensin system, 33631000 - Medicinal products for dermatology, 33632100 - Anti-inflammatory and anti-rheumatic products, 33632200 - Muscle relaxants, 33632300 - Antigout preparations, 33641200 - Other gynaecologicals, 33642200 - Corticosteroids for systemic use, 33661000 - Medicinal products for the nervous system, 33660000 - Medicinal products for the nervous system and sensory organs, 33661100 - Anaesthetics, 33661200 - Analgesics, 33661500 - Psycholeptics, 33661600 - Psychoanaleptics, 33661700 - Other nervous system medicinal products, 33662100 - Ophthalmologicals, 33670000 - Medicinal products for the respiratory system, 33674000 - Cough and cold preparations, 33675000 - Antihistamines for systemic use, 33692100 - Infusion solutions, 33692500 - Injectable solutions, 33692700 - Glucose solutions, 33696000 - Reagents and contrast media, 33651520 - Immunoglobulins, 15893000 - Dry goods, 33690000 - Various medicinal products, 33692800 - Dialysis solutions, 33692600 - Galenical solutions.
The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.
The TendersOnTime reference is 34207051. The purchaser document reference is 297986-2019.
This tender falls under Materials and Products, Agriculture and Foods in Bulgaria. Suppliers in these sectors can track similar Bulgaria tenders using CPV-based alerts.